Citation
83 FR 22501
Multiple canonical documents share this first-page citation.
- Prospective Grant of an Exclusive Patent License: Use of the CD47 Phosphorodiamidate Morpholino Oligomers for the Treatment, Prevention, and Diagnosis of Hematological Cancers Tuesday, May 15, 2018 83 FR 22501
- Prospective Grant of an Exclusive Patent License: Use of the CD47 Phosphorodiamidate Morpholino Oligomers for the Treatment, Prevention, and Diagnosis of Hematological Cancers Tuesday, May 15, 2018 83 FR 22501
- National Institute of General Medical Sciences; Notice of Closed Meeting Tuesday, May 15, 2018 83 FR 22501
- National Institute of General Medical Sciences; Notice of Closed Meeting Tuesday, May 15, 2018 83 FR 22501
- Federal Register Vol. 83, No.94, May 15, 2018 Tuesday, May 15, 2018 83 FR 22501